Trifarma Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TESTOSTERONE CYPIONATE USP, with a corresponding US DMF Number 21091.
Remarkably, this DMF maintains an Active status since its submission on November 21, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 22, 2014, and payment made on January 13, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II